We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+1.9%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$16.8B
AUM Growth
+$2.43B
(+17%)
Cap. Flow
+$2.2B
Cap. Flow
% of AUM
13.07%
Top 10 Holdings %
Top 10 Hldgs %
12.03%
Holding
1,764
New
564
Increased
341
Reduced
326
Closed
526
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$152M |
| 2 |
AT&T
T
|
+$119M |
| 3 |
Norfolk Southern
NSC
|
+$117M |
| 4 |
CSX Corp
CSX
|
+$115M |
| 5 |
Booking.com
BKNG
|
+$104M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$187M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$156M |
| 3 |
C.H. Robinson
CHRW
|
+$134M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$130M |
| 5 |
BCR
CR Bard Inc.
BCR
|
+$100M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.4% |
| 2 | Industrials | 9.58% |
| 3 | Consumer Staples | 7.89% |
| 4 | Financials | 7.87% |
| 5 | Healthcare | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Lexicon Pharmaceuticals
LXRX
$1.1B
| $1.58M | 0.01% |
+132,044
| New | +$1.38M |
|
727
Autodesk
ADSK
$52.6B
| $1.55M | 0.01% |
+26,613
| New | +$1.39M |
|
728
Weyerhaeuser
WY
$18.4B
| $1.55M | 0.01% |
+50,039
| New | +$1.34M |
|
729
PayPal
PYPL
$50.5B
| $1.54M | 0.01% |
40,000
-1,878,261
| -98% | -$67.9M |
|
|
ITCI
730
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.53M | 0.01% |
55,100
+45,730
| +488% | +$1.52M |
|
|
QTS
731
DELISTED
QTS REALTY TRUST, INC.
QTS
| $1.51M | 0.01% |
+31,869
| New | +$1.42M |
|
|
NUVA
732
DELISTED
NuVasive, Inc.
NUVA
| $1.5M | 0.01% |
30,900
-226,344
| -88% | -$10.3M |
|
733
American Financial Group
AFG
$12.1B
| $1.47M | 0.01% |
20,839
+12,755
| +158% | +$874K |
|
734
CALL
Warner Bros
WBD
$67.1B
| $1.43M | 0.01% |
+50,000
| New | +$1.34M |
|
735
Artisan Partners
APAM
$3.02B
| $1.42M | 0.01% |
46,122
+39,445
| +591% | +$1.15M |
|
|
HRC
736
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $1.42M | 0.01% |
+28,195
| New | +$1.33M |
|
|
EQGP
737
DELISTED
EQGP Holdings, LP
EQGP
| $1.39M | 0.01% |
51,612
-96,357
| -65% | -$2.13M |
|
738
Cisco
CSCO
$479B
| $1.39M | 0.01% |
48,857
-492,989
| -91% | -$12.7M |
|
|
CDK
739
DELISTED
CDK Global, Inc.
CDK
| $1.36M | 0.01% |
+29,155
| New | +$1.3M |
|
740
Dycom Industries
DY
$12.3B
| $1.35M | 0.01% |
+20,809
| New | +$1.27M |
|
741
CALL
Vince Holding Corp
VNCE
$86.8M
| $1.27M | 0.01% |
+20,000
| New | +$1.12M |
|
742
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.6B
| $1.25M | 0.01% |
51,000
+31,000
| +155% | +$719K |
|
|
CONN
743
CALL
DELISTED
Conn's Inc.
CONN
| $1.25M | 0.01% |
+100,000
| New | +$1.58M |
|
744
Cytokinetics
CYTK
$10.4B
| $1.25M | 0.01% |
176,559
-55,871
| -24% | -$408K |
|
745
iShares Russell 2000 Growth ETF
IWO
$15B
| $1.23M | 0.01% |
+9,254
| New | +$1.15M |
|
746
Cintas
CTAS
$81.3B
| $1.21M | 0.01% |
53,880
+43,840
| +437% | +$941K |
|
|
RTN
747
DELISTED
Raytheon Company
RTN
| $1.21M | 0.01% |
9,870
-50,405
| -84% | -$6.21M |
|
748
Groupon
GRPN
$1.02B
| $1.2M | 0.01% |
+15,039
| New | +$1.04M |
|
749
NETGEAR
NTGR
$635M
| $1.19M | 0.01% |
29,471
+11,029
| +60% | +$424K |
|
|
XLNX
750
DELISTED
Xilinx Inc
XLNX
| $1.18M | 0.01% |
24,916
-315,633
| -93% | -$14.8M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q1 2016 Portfolio in Review
As of Q1 2016, Balyasny Asset Management held 1,764 positions worth $16.8B, up 17% from $14.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Balyasny Asset Management deployed $2.2B of net new capital in Q1 2016, opening 564 new positions and adding to 341 existing holdings. Its largest new stake was Norfolk Southern: 1,546,641 shares worth $129M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Staples.
On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $187M trimmed.
- Balyasny Asset Management's largest Q1 2016 buy was Norfolk Southern: 1,546,641 shares worth $129M.
- Balyasny Asset Management added most to Marathon Petroleum in Q1 2016, an estimated $152M increase.
- Balyasny Asset Management's biggest Q1 2016 reduction was Teva Pharmaceuticals, cutting an estimated $187M.
- Balyasny Asset Management fully exited Union Pacific in Q1 2016, selling an estimated $79.7M.
- Balyasny Asset Management's ten largest holdings make up 12% of its $16.8B portfolio in Q1 2016.
- Balyasny Asset Management opened 564 new positions and closed 526 in Q1 2016.
- Balyasny Asset Management's portfolio value rose 17% quarter-over-quarter to $16.8B.
Based on Balyasny Asset Management's 13F filing for Q1 2016, filed 16 May 2016.